Company Filing History:
Years Active: 1987-1996
Title: Paul J Conlon, III: Innovator in Interleukin Research
Introduction
Paul J Conlon, III is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the research and development of interleukin proteins. With a total of 6 patents to his name, Conlon's work has advanced our understanding of these crucial biological molecules.
Latest Patents
Among his latest patents is the purification of homogeneous interleukin 1. This process utilizes various techniques, including ion exchange chromatography and dye-ligand affinity chromatography, to achieve high levels of purity. The successful purification has allowed for the determination of the amino acid composition and partial sequencing of interleukin 1. Another significant patent involves the gene encoding biologically active human interleukin 1. This innovation includes the preparation of double-stranded cDNA from activated human peripheral blood adherent mononuclear cells, which is then inserted into a plasmid vector for further transformation and identification of positive host cells.
Career Highlights
Conlon is currently associated with Immunex Corporation, where he continues to push the boundaries of interleukin research. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.
Collaborations
Throughout his career, Conlon has collaborated with esteemed colleagues such as Carl J March and Thomas P Hopp. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Paul J Conlon, III stands out as a prominent figure in the field of biotechnology, particularly in interleukin research. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and improving health outcomes.